Agilent Technologies (NYSE:A – Get Free Report) is set to post its quarterly earnings results after the market closes on Monday, November 20th. Analysts expect Agilent Technologies to post earnings of $1.34 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Tuesday, August 15th. The medical research company reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.66 billion. Agilent Technologies had a return on equity of 29.86% and a net margin of 16.20%. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same period last year, the firm posted $1.34 earnings per share. On average, analysts expect Agilent Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Agilent Technologies Trading Down 0.9 %
Shares of NYSE:A opened at $113.15 on Friday. Agilent Technologies has a 52-week low of $96.80 and a 52-week high of $160.26. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.68 and a current ratio of 2.29. The stock has a market capitalization of $33.11 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 2.01 and a beta of 1.04. The stock’s 50-day simple moving average is $109.96 and its two-hundred day simple moving average is $118.03.
Agilent Technologies Increases Dividend
Insiders Place Their Bets
In other Agilent Technologies news, VP Rodney Gonsalves sold 3,500 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $118.78, for a total value of $415,730.00. Following the sale, the vice president now owns 24,219 shares in the company, valued at $2,876,732.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Hedge Funds Weigh In On Agilent Technologies
Several institutional investors have recently made changes to their positions in the company. First Capital Advisors Group LLC. bought a new stake in Agilent Technologies during the second quarter valued at about $168,000. Covestor Ltd boosted its position in Agilent Technologies by 171.0% during the first quarter. Covestor Ltd now owns 1,241 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 783 shares in the last quarter. Brown Brothers Harriman & Co. boosted its position in Agilent Technologies by 169.5% during the first quarter. Brown Brothers Harriman & Co. now owns 1,237 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 778 shares in the last quarter. Financial Freedom LLC bought a new stake in Agilent Technologies during the fourth quarter valued at about $105,000. Finally, Pacific Center for Financial Services bought a new stake in Agilent Technologies during the first quarter valued at about $82,000.
Wall Street Analyst Weigh In
A number of research analysts recently commented on A shares. Evercore ISI lowered their price target on Agilent Technologies from $124.00 to $120.00 and set an “in-line” rating on the stock in a report on Wednesday, August 16th. Sanford C. Bernstein started coverage on Agilent Technologies in a report on Thursday, September 28th. They issued a “market perform” rating and a $123.00 price target on the stock. StockNews.com started coverage on Agilent Technologies in a report on Thursday, October 5th. They issued a “buy” rating on the stock. TD Cowen boosted their price target on Agilent Technologies from $145.00 to $147.00 and gave the stock an “outperform” rating in a report on Wednesday, August 16th. Finally, Robert W. Baird lowered their price target on Agilent Technologies from $144.00 to $140.00 and set an “outperform” rating on the stock in a report on Wednesday, August 16th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $143.94.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Five stocks we like better than Agilent Technologies
- The How And Why of Investing in Oil Stocks
- 3 large caps with red hot RSIs with upside
- Why is the Ex-Dividend Date Significant to Investors?
- Johnson Controls International: Nothing but upside for investors
- 3 Fintech Stocks With Good 2021 Prospects
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.